Mometasone furoate and olopatadine hydrochloride nasal spray (Ryaltris®) for treatment of moderate to severe nasal symptoms associated with allergic rhinitis
Mometasone furoate and olopatadine hydrochloride nasal spray (Ryaltris®) for treatment of moderate to severe nasal symptoms associated with allergic rhinitis
The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of mometasone furoate 25 micrograms and olopatadine hydrochloride equivalent to 600 micrograms nasal spray (Ryaltris®) for treatment of moderate to severe nasal symptoms associated with allergic rhinitis.